An official of a California-based diagnostic device company pleaded guilty Dec. 7 to charges that he defrauded investors by making false and misleading statements about the purported development of a COVID-19 test in a scheme that the government said led to “millions of dollars in investor losses” (United States v. Berman, No. 1:20-cr-00278-TNM (D.D.C.)). Keith Berman, the ch... Read More